Higher Risk Myelodysplastic Syndrome (MDS) (DBCOND0091897)

Identifiers

Synonyms

Higher-risk Myelodysplastic Syndromes / Higher risk myelodysplastic syndromes / Higher Risk Myelodysplastic Syndrome / Higher-Risk Myelodysplastic Syndrome (HR-MDS) / Higher Risk Myelodysplastic Syndrome (HR-MDS) / Higher-risk Myelodysplastic Syndrome

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06196203	A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes	Azacitidine Ligufalimab	treatment	2	recruiting
NCT06471946	VA Conditioning Regimen Allo-HSCT for Elderly Higher-risk MDS	Azacitidine Venetoclax	treatment	1 / 2	not_yet_recruiting
NCT06297941	Study of REM-422 in Patients With AML or Higher Risk MDS	REM-422	treatment	1	recruiting
NCT04417517	A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02)	Azacitidine Evorpacept	treatment	1 / 2	active_not_recruiting
NCT03417154	Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS	Cyclophosphamide Nivolumab	treatment	2	completed
NCT05209152	AMG 176 With Azacitidine in Subjects With Myelodysplastic Syndrome /Chronic Myelomonocytic Leukemia	Azacitidine Tapotoclax	treatment	1	completed
NCT05456269	A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS	Bisantrene Cedazuridine Cytarabine Decitabine	treatment	1	withdrawn
NCT02649790	Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications	Dexamethasone Eltanexor	treatment	1 / 2	active_not_recruiting
NCT01806116	Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation	Decitabine	treatment	4	unknown_status
NCT04068597	Study to Evaluate CCS1477 in Haematological Malignancies	Azacitidine Dexamethasone Inobrodib Pomalidomide Venetoclax	treatment	1 / 2	recruiting
NCT05320809	Study of 3D189 in Patients With Hematologic Malignancies	Galinpepimut-S	treatment	1	active_not_recruiting